Table 2.
AQP | Mutations | Comments | References |
---|---|---|---|
AQP0 | Ser235Ala | Produces defects to the plasma membrane translocation that induce congenic cataracts | [122] |
Arg33Cys | Reduces the cell-to-cell adhesion that is critical for lens transparency and homeostasis, inducing congenital lens cataracts | [129] | |
AQP1 | Thr157Ala Thr239Ala |
Abolish both the water permeability and the cationic conductance increase mediated by PKC phosphorylation in Xenopus oocytes | [130] |
Impair hypotonicity-induced translocation of AQP1 to the plasma membrane of HEK cells | [131] | ||
AQP2 | Cys181Trp | Impairs the plasma membrane translocation and the mutant accumulates in the endoplasmic reticulum (ER). This mutation was observed in a patient with congenital nephrogenic diabetes insipidus (NDI) | [132] |
Ser256Asp | Phosphorylation of serine 256 allows AQP2 trafficking to the plasma membrane. Mutations in this site abrogates the protein translocation. Thus, these mutations produce NDI, due the inability of the kidneys to concentrate urine | [133] | |
Ser256Ala | |||
Gly100Val | Both mutations were found in a Chinese family with congenital NDI, and both mutations retain AQP2 in the ER | [134] | |
Gln57Pro | |||
Ala147Thr | These three mutations were found in patients with NDI, impair translocation to the plasma membrane, and the mutant is retained at the ER | [135] | |
Thr126Met | |||
Asp68Ser | |||
Arg254Leu | This mutation lacks basopressin-mediated phosphorylation at S256, causing impaired transport to the plasma membrane. This mutation also causes NDI disease | [136] | |
AQP3 | Tyr19Ala | Partial disruption of AQP3 basolateral localization in MDCKII cells. A portion of AQP3 remains in the cytoplasm | [137] |
Leu21Ala-Leu22Ala | |||
Tyr19Ala-Arg20Ala-Leu21Ala-Leu22Ala | The mutation of this N-terminal motif produces complete retention of AQP3 in the cytoplasm of transfected MDCKII cells | ||
AQP4 | Ser180Ala | Ser180 is a PKC phosphorilation site. This mutation impairs the effect and produces a reduced water-permeable protein. | [138] |
Ser111Ala | Abolishes PKG-mediated phosphorylation of AQP4 in astrocytes cultured in vitro | [139] | |
Ser276Asp | This point mutation increases the rate of protein degradation. The effect was observed in AQP4-transfected MDSCK cells lysates | [140] | |
AQP5 | Ser156Glu | This phosphomimetic mutant increases the constitutive expression of AQP5 on the membrane but does not cause significant structural changes to the protein | [67] |
AQP6 | N-terminus | The short N-terminus of AQP6 is involved in its intracellular localization | [94] |
AQP7 | Ser10Ala/T11Ala | These mutations impair PKC phosphorylation of AQP7 and its interaction with perilipin 1 affecting the correct localization of AQP7 in the plasma membrane of adipocytes | [141] |
Gly264Val | Loss of glycerol transport function that impairs the reabsorption of glycerol by the kidneys inducing hyperglyceroluria in human children | [142] | |
AQP9 | Ser11Ala | This unphosphorylated mutant cannot be localized in the plasma membrane | [143] |
Ser11Asp | This phosphomimetic mutant enhances neutrophil polarization and chemotaxis | ||
AQP10 | His80Ala | Impairs glycerol permeability evidencing the role of His80 as a pH sensor | [71] |
Gly73Val | Impair glycerol permeability suggesting that the G73G74 motif mediates a gating mechanism between loop B and TM2 in the cytoplasmic aperture of the channel | ||
Gly73Phe | |||
AQP11 | Cys227Ser | Produces renal failure and death in sudden juvenile death syndrome (SJDS) in mice | [144] |
Alters the correct folding of AQP11, inducing endoplasmatic reticulum stress and apoptosis in cells of the proximal tubule | [145] |